Alexander Martin, OD, FAAO, Chief Medical Officer of Eyebot, describes Eye Care 3.0 as a shift from episodic, corrective visits to continuous, data-driven, preventive care. In conversation with AI in Eye Care’s Scot Morris, OD, Dr. Martin explains that he first heard the term “Eye Care 3.0” from Reade Fahs on LinkedIn, and Fahs’ post inspired him to keep hammering away at the idea, molding it and figuring out how to actually make 3.0 work.
Dr. Martin says, “Optometry 1.0 [is] the vision correction era of optometry,” while Optometry 2.0 moves toward medical management. Building on that past, Eye Care 3.0 combines frequent, accessible testing, richer multimodal imaging, continuous trend analysis and artificial intelligence that digests large amounts of longitudinal data. The model keeps clinicians central.
“The role of the optometrist is going to be tech-enabled,” Dr. Martin says. Optometrists will have to interpret the AI for patients and explain what the data showcases. Dr. Martin says the goal is not speed alone but smarter decision-making: “Prevention, predictive care, making sure that we’re becoming almost continuous. The only way you can analyze that much continuous data is through the use of AI.”
Embrace Scalable AI, Not Fear, To Close Eye Care Gap
Dr. Martin has two clear goals with Eyebot: to quantify cataracts, an urgent need he sees repeatedly on mission trips, and to improve diagnosis of keratoconus. He finds it frustrating when patients in their 30s arrive with vision that is not correctable and no one has explained why; he often asks, “Has anyone ever told you why your vision isn’t correctable in this eye? Or, both eyes?”
He focuses on building devices that help clinicians make those diagnoses reliably, even remotely. Dr. Martin also champions patient safety and the practical challenge of aligning industry, clinicians and patients around new tools. In many parts of the world there may be only one or two eye doctors per million people. Dr. Martin says this reality makes scalable diagnostic AI devices not just helpful, but essential.
With demand for eye care far greater than supply, Dr. Martin says. “There’s no need to be territorial. We all need to recognize that in the next 10 years … what is done within our four walls will change.” He says regulators and industry must find ways to keep practices viable without responding with fear. Dr. Morris readily agrees that care may move beyond the traditional office.
Dr. Martin stresses responsibility and validation: “Everything that we’re going to be doing has to have been clinically validated,” he says, and argues that freeing clinicians’ and patients’ time to see more people and provide more predictive care is the objective.
How Eye Care 3.0 Will Change The Patient Experience
With Eye Care 3.0, patients arrive at appointments with data already compiled: serial refractions, corneal metrics, retinal images and device-driven physiologic signals. That context changes diagnostic reasoning; a small refractive shift becomes meaningful when plotted against months or years of data. Routine exams turn into focused interventions guided by oculomics rather than single-point measurements. Remote or kiosk-based testing broadens access and flags urgent conditions earlier. Dr. Martin stresses that AI still needs clinician oversight in these settings: “All it’s doing is being our data gatherer. The doctor is still involved in making any decision that goes through that kiosk,” he says. This preserves clinician judgment while scaling screening capacity.
Dr. Martin sketches a near-future in which lens densitometry guides surgical decisions. He offers a familiar example: a patient who is told by another doctor that they would “never” need cataract surgery, yet presents with 20/25 or 20/30 vision and subtle changes that make it clear intervention is coming. He asks how to pinpoint the exact timing and quantify progression, noting that waitlists for cataract surgeons vary widely by location, arguing that until robotic cataract surgery is mainstream, variability will remain a problem. Using lens densitometry to prioritize patients, he suggests, could help line people up more effectively.
Key Challenges And Proposed Steps
Validation and bias are major hurdles to consider with Optometry 3.0. “Everything that we’re going to be doing has to have been clinically validated,” Dr. Martin says. Algorithms trained on limited or skewed data may not generalize. The solution requires intentionally broad data collection across regions and populations.
Dr. Martin proposes purpose-built clinics that act as research libraries, designed to gather standardized multimodal data and long-term outcomes. He argues participants should be compensated: “If you’re being a patient that’s creating the library, you should be paid for that.” Paying participants encourages enrollment, improves data diversity and supports ethical research.
Other challenges include scope-of-practice questions, regulation and clinician training. The profession must define how clinicians interpret AI outputs, explain findings to patients and coordinate care across teams and systems.
Close Gaps Where Clinicians Are Scarce
Trend-aware care can change everyday decisions. With serial data, clinicians can detect early cataract progression, prioritize surgery slots and identify conditions such as keratoconus years earlier. Combining refractive trends with physiologic data from wearables could reveal systemic issues like blood sugar changes sooner than traditional screening.
Eye Care 3.0 aims to reduce disparities by placing validated diagnostic tools in underserved areas and linking them to remote clinical oversight and referral networks. Scalable diagnostic platforms can help close gaps where clinician density is low and disease burden is high. Early detection, objective prioritization and streamlined referrals can improve outcomes and make better use of limited specialist capacity.
The Road Ahead
Eye Care 3.0 builds on current practice while changing how clinicians gather, interpret and act on information. The transition is technical and cultural: clinicians must learn to translate complex outputs into clear patient guidance, and systems must accept continuous validated data streams. Deployed responsibly, the 3.0 model expands access, strengthens preventive care and keeps clinicians central to decisions. That combination defines Eye Care 3.0 as a clinician-led, data-enabled future rather than a replacement for clinicians.
For more on this conversation, listen to this episode of Real Talk.
Author
